TIDMSN.

RNS Number : 3809S

Smith & Nephew Plc

02 October 2017

Directorate Change

2 October 2017

Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces that Marc Owen joined the Company on 1 October 2017 as Non-Executive Director and a member of the Audit Committee, as announced on 12 September 2017.

ends

Enquiries

 
                    Investors 
                    Ingeborg Øie 
                     Smith & Nephew                                  +44 (0) 20 7960 2285 
                    Media 
                    Charles Reynolds 
                     Smith & Nephew                                  +44 (0) 1923 477314 
                    Ben Atwell/ Simon Conway 
                    FTI Strategic Consulting                         +44 (0) 20 3727 1000

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2016 were almost $4.7 billion. Smith & Nephew is a member of the FTSE 100 (LSE:SN, NYSE:SNN).

For more information about Smith & Nephew, please visit our website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com.

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAGRBDGIUGBGRD

(END) Dow Jones Newswires

October 02, 2017 04:00 ET (08:00 GMT)

Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Smith & Nephew Charts.
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Smith & Nephew Charts.